(Q37719712)

English

Safety profiles of second-line tyrosine kinase inhibitors in patients with chronic myeloid leukaemia

scientific article published on 16 March 2010

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22 August 2017

1 reference

Europe PubMed Central

title

Safety profiles of second-line tyrosine kinase inhibitors in patients with chronic myeloid leukaemia (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22 August 2017

1 reference

Sara M Tinsley

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20345830

retrieved

22 August 2017

publication date

16 March 2010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20345830

retrieved

22 August 2017

published in

Journal of Clinical Nursing

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20345830

retrieved

22 August 2017

volume

19

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20345830

retrieved

22 August 2017

issue

9-10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20345830

retrieved

22 August 2017

page(s)

1207-1218

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20345830

retrieved

22 August 2017

cites work

Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2702.2009.03167.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1365-2702.2009.03167.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20345830

retrieved

22 August 2017

Fatcat ID

release_ba57jxltazgwncseeqryhgv3fe

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/ba57jxltazgwncseeqryhgv3fe

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

20345830

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20345830

retrieved

22 August 2017

(Q37719712)

Safety profiles of second-line tyrosine kinase inhibitors in patients with chronic myeloid leukaemia

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)